Adult CST-null mice maintain an increased number of oligodendrocytes

Journal of Neuroscience Research

Volumn 87, Issue 15, 2009, Pages 3403-3414

  Shroff, S M ^a,b   Pomicter, A D ^a   Chow, W N ^a   Fox, M A ^a   Colello, R J ^a   Henderson, S C ^a   Dupree, Jeff L ^a  

^a VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

^b NEW YORK UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Cell survival; Development; Oligodendrocyte; Sulfatide

Indexed keywords

CEREBROSIDE SULFOTRANSFERASE; SULFATIDE; SULFOTRANSFERASE; UNCLASSIFIED DRUG;

ANIMAL CELL; APOPTOSIS; ARTICLE; CELL COUNT; CELL LINEAGE; CELL PROLIFERATION; CELL SURVIVAL; CELLULAR DISTRIBUTION; CONTROLLED STUDY; MOUSE; NONHUMAN; NULL ALLELE; OLIGODENDROGLIA; PRIORITY JOURNAL; SPINAL CORD; ULTRASTRUCTURE;

AGING; ANIMALS; APOPTOSIS; CELL COUNT; CELL DIFFERENTIATION; CELL LINEAGE; CELL PROLIFERATION; CELL SURVIVAL; DISEASE MODELS, ANIMAL; GENE EXPRESSION REGULATION; HEREDITARY CENTRAL NERVOUS SYSTEM DEMYELINATING DISEASES; MICE; MICE, KNOCKOUT; MYELIN SHEATH; NERVE FIBERS, MYELINATED; OLIGODENDROGLIA; SPINAL CORD; STEM CELLS; SULFOGLYCOSPHINGOLIPIDS; SULFOTRANSFERASES; UP-REGULATION;

EID: 70449397376     PISSN: 03604012     EISSN: 10974547     Source Type: Journal    
DOI: 10.1002/jnr.22003     Document Type: Article

References (62)

1. Bansal R, Pfeiffer SE. 1989. Reversible inhibition of OL progenitor differentiation by a monoclonal antibody against surface galactolipids. Proc Natl Acad Sci U S A 86:6181-6185. (Pubitemid 19210621)
2. Bansal R, Pfeiffer SE. 1994. Inhibition of protein and lipid sulfation in OLs blocks biological responses to FGF-2 and retards cytoarchitectural maturation, but not developmental lineage progression. Dev Biol 162:511-524. (Pubitemid 24144127)
3. Bansal R, Gard AL, Pfeiffer SE. 1988. Stimulation of OL differentiation in culture by growth in the presence of a monoclonal antibody to sulfated glycolipid. J Neurosci Res 21:260-267. (Pubitemid 19031351)
4. Bansal R, Warrington AE, Gard AL, Ranscht B, Pfeiffer SE. 1989. Multiple and novel specificities of monoclonal antibodies O1, O4, and RmAb used in the analysis of OL development. J Neurosci Res 24:548-557. (Pubitemid 20015347)
5. Bansal R, Stefansson K, Pfeiffer SE. 1992. Proligodendroblast antigen (POA), a developmental antigen expressed by A007/O4-positive OL progenitors prior to the appearance of sulfatide and galactocerebroside. J Neurochem 58:2221-2229.
6. Bansal R, Winkler S, Bheddah S. 1999. Negative regulation of OL differentiation by galactosphingolipids. J Neurosci 19:7913-7924.
7. Barres BA, Hart IK, Coles HS, Burne JF, Voyvodic JT, Richardson WD, Raff MC. 1992. Cell death and control of cell survival in the OL lineage. Cell 70:31-46.
8. Barres BA, Jacobson MD, Schmid R, Sendtner M, Raff MC. 1993a. Does OL survival depend on axons? Curr Biol 3:489-497.
9. Barres BA, Schmid R, Sendnter M, Raff MC. 1993b. Multiple extracellular signals are required for long-term OL survival. Development 118:283-295. (Pubitemid 23191629)
10. Bhat RV, Axt KJ, Fosnaugh JS, Smith KJ, Johnson KA, Hill DE, Kinzler KW, Baraban JM. 1996. Expression of the APC tumor suppressor protein in oligodendroglia. Glia 17:169-174. (Pubitemid 26309444)
11. Boggs JM, Wang H. 2001. Effect of liposomes containing cerebroside and cerebroside sulfate on cytoskeleton of cultured OLs. J Neurosci Res 66:242-253. (Pubitemid 32912293)
12. Bosio A, Binczek E, Stoffel W. 1996. Functional breakdown of the lipid bilayer of the myelin membrane in central and peripheral nervous system by disrupted galactocerebroside synthesis. Proc Natl Acad Sci U S A 93:13280-13285. (Pubitemid 26382807)
13. + glial cell proliferation and OL generation in the hypomyelinating mutant shiverer. Glia 48:51-63.
14. Calver AR, Hall AC, Yu WP, Walsh FS, Heath JK, Betsholtz C, Richardson WD. 1998. OL population dynamics and the role of PDGF in vivo. Neuron 20:869-882. (Pubitemid 28247393)
15. Cestaro B, Marchesini S, Cervato G, Viani P, Vesely S. 1984. Bilayermicelle transition in phosphatidylcholine-sulfatide mixtures. Ital J Biochem 33:381-391.
16. Coetzee T, Fujita N, Dupree J, Shi R, Blight A, Suzuki K, Suzuki K, Popko B. 1996. Myelination in the absence of galactocerebroside and sulfatide: normal structure with abnormal function and regional instability. Cell 86:209-219. (Pubitemid 26286104)
17. Dubois-Dalcq M, Niedieck B, Buyse M. 1970. Action of anti-cerebroside sera on myelinated nervous tissue cultures. Pathol Eur 5:331-347.
18. Dupree JL, Popko B. 1999. Genetic dissection of myelin galactolipid function. J Neurocytol 28:271-279. (Pubitemid 30321009)
19. Dupree JL, Coetzee T, Blight A, Suzuki K, Popko B. 1998. Myelin galactolipids are essential for proper node of Ranvier formation in the CNS. J Neurosci 18:1642-1649. (Pubitemid 28103072)
20. Dupree JL, Mason JL, Marcus JR, Stull M, Levinson R, Matsushima GK, Popko B. 2005. OLs assist in the maintenance of sodium channel clusters independent of the myelin sheath. Neuron Glia Biol 1:1-14.
21. Dyer CA, Benjamins JA. 1990. Glycolipids and transmembrane signaling: antibodies to galactocerebroside cause an influx of calcium in OLs. J Cell Biol 111:625-633. (Pubitemid 20239874)
22. 2+ responses in OLs. J Neurosci Res 30:699-711.
23. Fry JM, Weissbarth S, Lehrer GM, Bornstein MB. 1974. Cerebroside antibody inhibits sulfatide synthesis and myelination and demyelinates in cord tissue cultures. Science 183:540-542.
24. Fuss B, Mallon B, Phan T, Ohlemeyer C, Kirchhoff F, Nishiyama A, Macklin WB. 2000. Purification and analysis of in vivo-differentiated OLs expressing the green fluorescent protein. Dev Biol 218:259-274. (Pubitemid 30101974)
25. -) under different mitogenic control. Neuron 5:615-625.
26. Gokhan S, Marin-Husstege M, Yung SY, Fontanez D, Casaccia-Bonnefil P, Mehler MF. 2005. Combinatorial profiles of OL-selective classes of transcriptional regulators differentially modulate myelin basic protein gene expression. J Neurosci 25:8311-8321. (Pubitemid 41292126)
27. Hirahara Y, Bansal R, Honke K, Ikenaka K, Wada Y. 2004. Sulfatide is a negative regulator of OL differentiation: development in sulfatide-null mice. Glia 45:269-277. (Pubitemid 38222255)
28. Honke K, Hirahara Y, Dupree J, Suzuki K, Popko B, Fukushima K, Fukushima J, Nagasawa T, Yoshida N, Wada Y, Taniguchi N. 2002. Paranodal junction formation and spermatogenesis require sulfoglycolipids. Proc Natl Acad Sci U S A 99:4227-4232. (Pubitemid 34285968)
29. Ishibashi T, Dupree JL, Ikenaka K, Hirahara Y, Honke K, Peles E, Popko B, Suzuki K, Nishino H, Baba H. 2002. A myelin galactolipid, sulfatide, is essential for maintenance of ion channels on myelinated axon but not essential for initial cluster formation. J Neurosci 22:6507-6514. (Pubitemid 35386407)
30. Keirstead HS, Blakemore WF. 1999. The role of OLs and OL progenitors in CNS remyelination. Adv Exp Med Biol 468:183-197.
31. Ligon KL, Alberta JA, Kho AT, Weiss J, Kwaan MR, Nutt CL, Louis DN, Stiles CD, Rowitch DH. 2004. The oligodendroglial lineage marker OLIG2 is universally expressed in diffuse gliomas. J Neuropathol Exp Neurol 63:499-509. (Pubitemid 38669670)
32. Lu QR, Yuk D, Alberta JA, Zhu Z, Pawlitzky I, Chan J, McMahon AP, Stiles CD, Rowitch DH. 2000. Sonic hedgehog-regulated OL lineage genes encoding bHLH proteins in the mammalian central nervous system. Neuron 25:317-329. (Pubitemid 30831788)
33. Marcus J, Dupree JL, Popko B. 2000. Effects of galactolipid elimination on OL development and myelination. Glia 30:319-328. (Pubitemid 30334333)
34. Marcus J, Honigbaum S, Shroff S, Honke K, Rosenbluth J, Dupree JL. 2006. Sulfatide is essential for the maintenance of CNS myelin and axon structure. Glia 53:372-381. (Pubitemid 43294747)
35. Masahira N, Takebayashi H, Ono K, Watanabe K, Ding L, Furusho M, Ogawa Y, Nabeshima Y, Alvarez-Buylla A, Shimizu K, Ikenaka K. 2006. Olig2-positive progenitors in the embryonic spinal cord give rise not only to motoneurons and OLs, but also to a subset of astrocytes and ependymal cells. Dev Biol 293:358-369.
36. McGinn MJ, Sun D, Schneider SL, Alexander JK, Colello RJ. 2004. Epidermal growth factor-induced cell proliferation in the adult rat striatum. Brain Res 1007:29-38. (Pubitemid 38520170)
37. Messersmith DJ, Murtie JC, Le TQ, Frost EE, Armstrong RC. 2000. Fibroblast growth factor 2 (FGF2) and FGF receptor expression in an experimental demyelinating disease with extensive remyelination. J Neurosci Res 62:241-256.
38. Menn B, Garcia-Verdugo JM, Yaschine C, Gonzalez-Perez O, Rowitch D, Alvarez-Buylla A. 2006. Origin of OLs in the subventricular zone of the adult brain. J Neurosci 26:7907-7918. (Pubitemid 44315160)
39. Miller RH. 2002. Regulation of OL development in the vertebrate CNS. Prog Neurobiol 67:451-467.
40. Molander-Melin M, Pernber Z, Franken S, Gieselmann V, Månsson JE, Fredman P. 2004. Accumulation of sulfatide in neuronal and glial cells of arylsulfatase A deficient mice. J Neurocytol 33:417-427. (Pubitemid 39463164)
41. Murtie JC, Zhou YX, Le TQ, Armstrong RC. 2005. In vivo analysis of OL lineage development in postnatal FGF2 null mice. Glia 49:542-554.
42. Nait-Oumesmar B, Picard-Riera N, Kerninon C, Decker L, Seilhean D, Höglinger GU, Hirsch EC, Reynolds R, Baron-Van Evercooren A. 2007. Activation of the subventricular zone in multiple sclerosis: evidence for early glial progenitors. Proc Natl Acad Sci U S A 104:4694-4699. (Pubitemid 47186287)
43. Norton W, Cammer W. 1984. Isolation and characterization of myelin. In: Morell P, editor. Myelin. New York: Plenum. p 147-180.
44. Owens GC, Bunge RP. 1990. Schwann cells depleted of galactocerebroside express myelin-associated glycoprotein and initiate but do not continue the process of myelination. Glia 3:118-124.
45. Pernber Z, Molander-Melin M, Berthold CH, Hansson E, Fredman P. 2002. Expression of the myelin and OL progenitor marker sulfatide in neurons and astrocytes of adult rat brain. J Neurosci Res 69:86-93. (Pubitemid 34734168)
46. Pernet V, Joly S, Christ F, Dimou L, Schwab ME. 2008. Nogo-a and myelin-associated glycoprotein differently regulate OL maturation and myelin formation. J Neurosci 28:7435-7444.
47. Pfeiffer SE, Warrington AE, Bansal R. 1993. The OL and its many cellular processes. Trends Cell Biol 3:191-197.
48. Ranscht B, Clapshaw PA, Price J, Noble M, Seifert W. 1982. Development of OLs and Schwann cells studied with a monoclonal antibody against galactocerebroside. Proc Natl Acad Sci U S A 79:2709-2713. (Pubitemid 12068428)
49. Ranscht B, Wood PM, Bunge RP. 1987. Inhibition of in vitro peripheral myelin formation by monoclonal anti-galactocerebroside. J Neurosci 7:2936-2947.
50. Rosenbluth J, Liu Z, Guo D, Schiff R. 1994. Inhibition of CNS myelin development in vivo by implantation of anti-GalC hybridoma cells. J Neurocytol 23:699-707. (Pubitemid 24352278)
51. Rosenbluth J, Liang WL, Liu Z, Guo D, Schiff R. 1995. Paranodal structural abnormalities in rat CNS myelin developing in vivo in the presence of implanted O1 hybridoma cells. Brain Res 686:143-149.
52. Roth GA, Röyttä M, Yu RK, Raine CS, Bornstein MB. 1985. Antisera to different glycolipids induce myelin alterations in mouse spinal cord tissue cultures. Brain Res 339:9-18. (Pubitemid 15073895)
53. Rowitch DH. 2004. Glial specification in the vertebrate neural tube. Nat Rev Neurosci 5:409-419.
54. Saida K, Saida T, Brown MJ, Silberberg DH. 1979. In vivo demyelination induced by intraneural injection of anti-galactocerebroside serum: a morphologic study. Am J Pathol 95:99-116.
55. Saito M, Macala LJ, Roth GA, Bornstein MB, Yu RK. 1986. Effect of antiglycolipid antisera on the lipid composition of cultured mouse spinal cords. Exp Neurol 92:752-756. (Pubitemid 16074651)
56. Sergott RC, Brown MJ, Silberberg DH. 1986. Remyelination follows antibody-induced central nervous system demyelination. Ann Neurol 20:94-98 (Pubitemid 16063243)
57. Sohn J, Natale J, Chew LJ, Belachew S, Cheng Y, Aguirre A, Lytle J, Nait-Oumesmar B, Kerninon C, Kanai-Azuma M, Kanai Y, Gallo V. 2006. Identification of Sox17 as a transcription factor that regulates OL development. J Neurosci 26:9722-9735. (Pubitemid 44427711)
58. Sun D, Colello RJ, Daugherty WP, Kwon TH, McGinn MJ, Harvey HB, Bullock MR. 2005. Cell proliferation and neuronal differentiation in the dentate gyrus in juvenile ans adult rats following traumatic brain injury. J Neurotrauma 22:95-105.
59. Taylor CM, Marta CB, Bansal R, Pfeiffer SE. 2004. The transport, assembly, and function of myelin lipids. In: Lazzarini RA, editor. Myelin biology and disorders, vol 1. New York: Academic Press. p 57-88.
60. Trapp BD, Nishiyama A, Cheng D, Macklin W. 1997. Differentation and death of premyelinating oligodendrocytes in developing rodent brain. J Cell Biol 137:459-468. (Pubitemid 27181297)
61. Vana AC, Lucchinetti CF, Le TQ, Armstrong RC. 2007. Myelin transcription factor 1 (Myt1) expression in demyelinated lesions of rodent and human CNS. Glia 55:687-697.
62. Zhou Q, Wang S, Anderson DJ. 2000. Identification of a novel family of OL lineage-specific basic helix-loop-helix transcription factors. Neuron 25:331-343. (Pubitemid 30831789)